ProShares UltraPro Short QQQ, CVS Health, Chevron, Southern, NIKE, Pfizer, and PepsiCo are the seven Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend stocks are shares of companies that regularly distribute a portion of their profits to shareholders, typically in the form of cash payments called dividends. Investors may seek these stocks for income and potential long-term growth, although dividend payments are not guaranteed and can be reduced or suspended. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.
ProShares UltraPro Short QQQ (SQQQ)
ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.
NASDAQ SQQQ traded down $1.29 during trading hours on Wednesday, reaching $41.45. The stock had a trading volume of 61,488,919 shares, compared to its average volume of 55,594,250. ProShares UltraPro Short QQQ has a 52-week low of $31.42 and a 52-week high of $90.71. The stock has a fifty day moving average of $37.09 and a 200 day moving average of $50.03.
Read Our Latest Research Report on SQQQ
CVS Health (CVS)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Shares of NYSE:CVS traded down $10.80 during midday trading on Wednesday, reaching $80.61. The company's stock had a trading volume of 25,665,710 shares, compared to its average volume of 8,416,404. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The stock has a fifty day moving average of $91.08 and a 200 day moving average of $88.87. CVS Health has a twelve month low of $69.51 and a twelve month high of $110.68. The firm has a market capitalization of $103.10 billion, a PE ratio of 21.38, a P/E/G ratio of 0.82 and a beta of 0.58.
Read Our Latest Research Report on CVS
Chevron (CVX)
Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant.
NYSE:CVX traded down $8.93 during mid-day trading on Wednesday, hitting $216.34. The company's stock had a trading volume of 6,667,254 shares, compared to its average volume of 10,255,364. The business's fifty day moving average is $214.06 and its two-hundred day moving average is $193.68. The stock has a market cap of $427.44 billion, a price-to-earnings ratio of 15.84, a PEG ratio of 0.54 and a beta of 0.47. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.25 and a quick ratio of 0.98. Chevron has a 1 year low of $146.49 and a 1 year high of $236.48.
Read Our Latest Research Report on CVX
Southern (SO)
The Southern Company, through its subsidiaries, engages in the generation, transmission, and distribution of electricity. The company also develops, constructs, acquires, owns, and manages power generation assets, including renewable energy projects and sells electricity in the wholesale market; and distributes natural gas in Illinois, Georgia, Virginia, and Tennessee, as well as provides gas marketing services, gas distribution operations, and gas pipeline investments operations.
Shares of NYSE:SO traded up $0.17 during trading on Wednesday, reaching $93.92. 12,392,702 shares of the company's stock traded hands, compared to its average volume of 5,845,514. The company has a quick ratio of 0.59, a current ratio of 0.79 and a debt-to-equity ratio of 1.62. The firm has a market cap of $108.04 billion, a PE ratio of 22.50, a P/E/G ratio of 2.49 and a beta of 0.30. Southern has a fifty-two week low of $81.69 and a fifty-two week high of $99.58. The company has a 50-day simple moving average of $87.96 and a 200-day simple moving average of $92.42.
Read Our Latest Research Report on SO
NIKE (NKE)
NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, accessories, and services worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks.
Shares of NYSE:NKE traded up $1.87 during midday trading on Wednesday, hitting $40.35. The company's stock had a trading volume of 25,148,422 shares, compared to its average volume of 24,647,313. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.39 and a current ratio of 2.07. The company has a market cap of $59.93 billion, a P/E ratio of 19.38, a price-to-earnings-growth ratio of 4.57 and a beta of 1.01. The business's 50 day simple moving average is $36.86 and its 200 day simple moving average is $46.00. NIKE has a 12-month low of $31.97 and a 12-month high of $69.14.
Read Our Latest Research Report on NKE
Pfizer (PFE)
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.
Pfizer stock traded up $0.69 during midday trading on Wednesday, reaching $30.69. 30,514,163 shares of the stock traded hands, compared to its average volume of 39,736,445. Pfizer has a 12-month low of $23.62 and a 12-month high of $31.06. The firm has a market cap of $174.91 billion, a PE ratio of 40.32, a price-to-earnings-growth ratio of 2.08 and a beta of 0.31. The company has a current ratio of 1.27, a quick ratio of 0.96 and a debt-to-equity ratio of 0.71. The company has a 50-day simple moving average of $28.64 and a two-hundred day simple moving average of $26.84.
Read Our Latest Research Report on PFE
PepsiCo (PEP)
PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region.
Shares of PEP stock traded up $5.55 on Wednesday, reaching $142.82. 6,115,850 shares of the stock were exchanged, compared to its average volume of 8,193,165. The business's 50 day moving average price is $133.28 and its 200 day moving average price is $145.82. The company has a market capitalization of $194.62 billion, a price-to-earnings ratio of 17.92, a PEG ratio of 4.19 and a beta of 0.31. PepsiCo has a twelve month low of $123.47 and a twelve month high of $171.48. The company has a current ratio of 0.94, a quick ratio of 0.76 and a debt-to-equity ratio of 1.90.
Read Our Latest Research Report on PEP
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ProShares UltraPro Short QQQ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProShares UltraPro Short QQQ wasn't on the list.
While ProShares UltraPro Short QQQ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
